SCHEMBL10811050

SCHEMBL10811050

O=c1ncc(Cl)cn1COCc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 1/20 0.43
▸ ALKBH1 Q13686 1/20 0.39
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ RXRA P19793 1/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ IDO1 P14902 2/20 0.36
▸ AGXT P21549 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ MAOA P21397 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10811918 0.90 EGLN1 (0.39) EGLN1ALKBH1RAB9ASMN1; SMN2NPC1
SCHEMBL11018085 0.90 RXRA (0.41) EGLN1RAB9ASMN1; SMN2NPC1RXRA
SCHEMBL10816686 0.90 L3MBTL1 (0.43) EGLN1ALKBH1RAB9ASMN1; SMN2NPC1
SCHEMBL10813483 0.88 EGLN1 (0.43) EGLN1ALKBH1RAB9ASMN1; SMN2NPC1
SCHEMBL10816545 0.87 EGLN1 (0.41) EGLN1ALKBH1RAB9ASMN1; SMN2NPC1
SCHEMBL10814782 0.87 EGLN1 (0.41) EGLN1ALKBH1RAB9ASMN1; SMN2NPC1
SCHEMBL11021894 0.86 ALKBH1 (0.41) ALKBH1RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL10815000 0.85 RXRA (0.46) EGLN1ALKBH1RAB9ASMN1; SMN2NPC1
SCHEMBL10813796 0.84 RAB9A (0.46) EGLN1RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL11037277 0.80 EGLN1 (0.44) EGLN1RXRAGRIN1GRIN2BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0087326-B1 SUBSTITUTED PYRIMIDIN-2-ONES AND THE SALTS THEREOF NYCOMED AS (NO) 1987-05-13 — — EP claimed
US-4539324-A ANTICANCER AGENTS NYEGAARD & CO. A/S (NO) 1985-09-03 — — US claimed
EP-0087326-A1 Substituted pyrimidin-2-ones and the salts thereof NYCOMED AS (NO) 1983-08-31 — — EP claimed
EP-0087326-B1 SUBSTITUTED PYRIMIDIN-2-ONES AND THE SALTS THEREOF NYCOMED AS (NO) 1987-05-13 — — EP disclosed
US-4539324-A ANTICANCER AGENTS NYEGAARD & CO. A/S (NO) 1985-09-03 — — US disclosed
EP-0087326-A1 Substituted pyrimidin-2-ones and the salts thereof NYCOMED AS (NO) 1983-08-31 — — EP disclosed
Send feedback